Latest Search
Quote
| Back Zoom + Zoom - | |
|
<Research>M Stanley: GALAXY ENT (00027.HK) TP $44 as Quarterly Results Beat w/ Higher DPS
Recommend 0 Positive 7 Negative 2 |
|
|
|
|
GALAXY ENT (00027.HK)'s 4Q25 corporate EBITDA amounted to $4.296 billion, up 33% YoY, 5% higher than Morgan Stanley's forecast, 9% above market consensus, Morgan Stanley released a research report saying. Hold-adjusted corporate EBITDA was $3.565 billion, up 9% YoY. Therefore, the broker kept rating at Overweight on GALAXY ENT, with a target price of $44. Its 2025 DPS was $1.50, marking a YoY increase of 50%, better than expected. However, the dividend yield of 3.6% is lower than 5-6% for Sands, MGM and Wynn. AASTOCKS Financial News Website: www.aastocks.com |
|
